Brainsway Ltd. ADR (BWAY)
NASDAQ (NMS) NASDAQ (NMS) Primary 
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
BrainsWay stock rises after Optum expands Deep TMS coverage for adolescents, boosting reimbursement visibility.
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call Transcript
BrainsWay Ltd. ( BWAY ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors, LLC Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division Carl Byrnes - Northland Capital Markets, Research Division Raghuram Selvaraju - H.C.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock
Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet
The mean of analysts' price targets for Brainsway (BWAY) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript
BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Carl Edward Byrnes - Northland Capital Markets, Research Division Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Garth Russell - Unidentified Company Operator Good day, and welcome to the BrainsWay Second Quarter 2025 Earnings Conference Call.
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
Let's take a look at four stocks, CPRX, GAMB, ORN and BWAY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
Is the Options Market Predicting a Spike in Brainsway Stock?
Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.
